NCT05722015 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 251
- group Id
- BG001
- value
- 126
- group Id
- BG002
- value
- 377
- units
- Participants
- groups
- description
- Participants with treatment-naïve metastatic NSCLC receive 790 mg of Pembrolizumab Formulated With Berahyaluronidase Alfa via subcutaneous (SC) injection on Day 1 of each 6-week cycle for 18 cycles (up to approximately 108 weeks) in combination with platinum doublet chemotherapy.
- id
- BG000
- title
- Arm 1: Pembrolizumab Formulated With Berahyaluronidase Alfa + Platinum Doublet Chemotherapy
- description
- Participants with treatment-naïve metastatic NSCLC receive 400 mg pembrolizumab intravenous (IV) infusion in combination with platinum doublet chemotherapy.
- id
- BG001
- title
- Arm 2: Pembrolizumab + Platinum Doublet Chemotherapy
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.6
- value
- 64.7
- group Id
- BG001
- spread
- 8.5
- value
- 64.8
- group Id
- BG002
- spread
- 9.2
- value
- 64.8
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 69
- group Id
- BG001
- value
- 40
- group Id
- BG002
- value
- 109
- title
- Female
- measurements
- group Id
- BG000
- value
- 182
- group Id
- BG001
- value
- 86
- group Id
- BG002
- value
- 268
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 115
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 177
- group Id
- BG001
- value
- 85
- group Id
- BG002
- value
- 262
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 6
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 110
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 10
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 158
- group Id
- BG001
- value
- 78
- group Id
- BG002
- value
- 236
- title
- White
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 15
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- population Description
- All randomized participants.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 251
- group Id
- BG001
- value
- 126
- group Id
- BG002
- value
- 377
- units
- Participants
- groups
- description
- Participants with treatment-naïve metastatic NSCLC receive 790 mg of Pembrolizumab Formulated With Berahyaluronidase Alfa via subcutaneous (SC) injection on Day 1 of each 6-week cycle for 18 cycles (up to approximately 108 weeks) in combination with platinum doublet chemotherapy.
- id
- BG000
- title
- Arm 1: Pembrolizumab Formulated With Berahyaluronidase Alfa + Platinum Doublet Chemotherapy
- description
- Participants with treatment-naïve metastatic NSCLC receive 400 mg pembrolizumab intravenous (IV) infusion in combination with platinum doublet chemotherapy.
- id
- BG001
- title
- Arm 2: Pembrolizumab + Platinum Doublet Chemotherapy
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.6
- value
- 64.7
- group Id
- BG001
- spread
- 8.5
- value
- 64.8
- group Id
- BG002
- spread
- 9.2
- value
- 64.8
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 69
- group Id
- BG001
- value
- 40
- group Id
- BG002
- value
- 109
- title
- Female
- measurements
- group Id
- BG000
- value
- 182
- group Id
- BG001
- value
- 86
- group Id
- BG002
- value
- 268
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 115
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 177
- group Id
- BG001
- value
- 85
- group Id
- BG002
- value
- 262
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 6
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 110
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 10
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 158
- group Id
- BG001
- value
- 78
- group Id
- BG002
- value
- 236
- title
- White
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 15
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- population Description
- All randomized participants.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle